Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/10702
Title: | Therapeutic vaccines for autoimmune Diseases | Authors: | PANNEMANS, Kim HELLINGS, Niels STINISSEN, Piet |
Issue Date: | 2010 | Publisher: | Elsevier | Source: | Drug Discovery Today: Therapeutic Strategies, 6(1), p. 39-44 | Abstract: | The immune system has developed several checkpoints to prevent the induction of autoimmune diseases like multiple sclerosis and rheumatoid arthritis. Autoreactive T cells are negatively selected in the thymus but can escape this selection procedure. Peripherally, they are further controlled by homeostatic mechanisms and regulatory T cells (Tregs). Genetic and exogenous factors as well as a disbalanced functioning of Tregs may all influence these checkpoints and contribute to the breakdown of tolerance against ‘self’. Re-establishment of tolerance can be achieved by different vaccination strategies, which are divided into three major groups based on the composition of the vaccine: DNA vaccination, peptide-based-vaccination and T cell vaccination. This review summarizes the mechanisms, clinical trials and pros and cons of these different vaccination strategies. | Document URI: | http://hdl.handle.net/1942/10702 | ISSN: | 1359-6446 | e-ISSN: | 1878-5832 | DOI: | 10.1016/j.ddstr.2009.11.001 | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S1740677309000278-main.pdf Restricted Access | Published version | 218.76 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
2
checked on Sep 3, 2020
Page view(s)
74
checked on Aug 31, 2022
Download(s)
52
checked on Aug 31, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.